| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/27/1993 | WO1993009798A1 Therapeutic and diagnostic methods based on tissue specific nt-3 expression and receptor binding |
| 05/27/1993 | WO1993009792A1 Chimeric mammals with human hematopoietic cells |
| 05/27/1993 | DE4238806A1 Methicillin-resistant staphylococcus aureus (MRSA)detection method - by detection of MRSA penicillin binding protein (PBP)2 antigen-antibody complex, and synthetic MRSA PBP2 peptides |
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 05/27/1993 | CA2123874A1 Methods for detecting and isolating upa-r and inhibiting the binding of upa to upa-r |
| 05/27/1993 | CA2123676A1 Expression of proteins on bacterial surface |
| 05/27/1993 | CA2123582A1 Recombinant mammalian calcitonin receptors and uses thereof |
| 05/27/1993 | CA2123495A1 B-ketoacyl-acp synthetase ii genes from plants |
| 05/27/1993 | CA2123316A1 High molecular weight collagen-like protein polymers |
| 05/27/1993 | CA2123213A1 Ganglioside analogs |
| 05/27/1993 | CA2123210A1 Protein allergens of the species cynodon dactylon |
| 05/27/1993 | CA2123121A1 Recombinant vaccine against lyme disease |
| 05/27/1993 | CA2122725A1 Chimeric mammals with human hematopoietic cells |
| 05/26/1993 | EP0543091A2 Monoclonal antibody reacting with Pseudomonas aeruginosa |
| 05/26/1993 | EP0542971A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-$g(b) SUPERFAMILY |
| 05/26/1993 | EP0542970A1 Nucleotide and peptide sequences of an isolate of the hepatitis c virus, diagnostic and therapeutic applications thereof |
| 05/26/1993 | EP0542949A1 Hepatitis a virus strain, method for the isolation of said virus strains and hepatitis a vaccines |
| 05/26/1993 | EP0542897A1 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors. |
| 05/26/1993 | EP0542843A1 Cloning and expression of toxoplasma antigens and use of recombinant antigens |
| 05/26/1993 | EP0542810A1 Methods for the production of proteins with a desired function |
| 05/26/1993 | EP0542770A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 05/26/1993 | EP0528881A4 Methods for phenotype creation from multiple gene populations |
| 05/26/1993 | EP0167575B1 Cardiodilatine, a new peptide hormone and production process thereof |
| 05/26/1993 | CN1020924C Production of pluripotent granule cell colony stimulating factor |
| 05/25/1993 | US5214132 Polypeptide derivatives of human granulocyte colony stimulating factor |
| 05/25/1993 | US5214033 Factor VIII coagulant polypeptides |
| 05/25/1993 | US5213977 Serine protease from cytotoxic killer cells |
| 05/19/1993 | EP0542309A1 Hair care product |
| 05/19/1993 | EP0542287A2 Anti-human ornithine decarboxylase antibody |
| 05/19/1993 | EP0542255A1 Monoclonal antibody recognizing the C-terminus of hBNP |
| 05/19/1993 | EP0542145A1 Oligosaccharides with antigenic determinants from the jelly coat of amphibian eggs |
| 05/19/1993 | EP0541920A1 Interleukin-1 inhibitors |
| 05/19/1993 | EP0541701A1 INTERLEUKIN-4 AND INTERLEUKIN-1$g(b) SYNERGISTICALLY INDUCE VCAM-1 |
| 05/19/1993 | EP0541691A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 05/19/1993 | EP0541663A1 Peptides and pharmaceutical compositions having glycoprotein hormone agonistic or antagonistic activity |
| 05/19/1993 | EP0541645A1 Method of purifying cytokeratin 20, and the use of cytokeratin 20 to produce antibodies |
| 05/19/1993 | EP0541629A1 CLONING AND EXPRESSION OF A RHOPTRY ASSOCIATED PROTEIN OF $i(P.FALCIPARUM) |
| 05/19/1993 | EP0541556A1 Stabilization of biological macromolecular substances and other organic compounds |
| 05/19/1993 | EP0343186B1 MOLECULES COMPRISING AT LEAST ONE PEPTIDIC SEQUENCE CARRYING ONE OR A PLURALITY OF EPITOPES CHARACTERIZING A PROTEIN PRODUCED BY $i(P. FALCIPARUM) IN HEPATOCYTES AND COMPOSITIONS CONTAINING THEM |
| 05/19/1993 | DE3844628C2 New antibodies reactive with N-glycan structures of cell membrane surf |
| 05/18/1993 | US5212290 Monoclonal and polyclonal antibodies |
| 05/18/1993 | US5212287 Pentapeptide synthesis |
| 05/18/1993 | US5212156 Srif-related peptides and uses thereof |
| 05/18/1993 | US5212085 Monoclonal antibodies |
| 05/18/1993 | US5212074 Genetic material encoding new insulin-like growth factor binding protein igfbp-6 |
| 05/18/1993 | US5212072 Genetic engineering and DNA sequences |
| 05/18/1993 | US5211657 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
| 05/18/1993 | CA1317899C Stabilization of antibodies |
| 05/18/1993 | CA1317880C Method of reducing tissue damage at an inflammatory site using a monoclonal antibody |
| 05/13/1993 | WO1993009437A2 Nuclear matrix protein fluid assay |
| 05/13/1993 | WO1993009436A1 A method for detecting a differentiation marker in normal and carcinoma cells and in biological samples and body fluid |
| 05/13/1993 | WO1993009234A2 Suppressor and progenitor cells |
| 05/13/1993 | WO1993009230A1 Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids |
| 05/13/1993 | WO1993009228A1 TGF-β TYPE RECEPTOR cDNAS AND USES THEREFOR |
| 05/13/1993 | WO1993009226A1 Novel endopeptidase and peptide substrate cleaving and inactivating activity thereof |
| 05/13/1993 | WO1993009221A1 Targeted delivery of virus vector to mammalian cells |
| 05/13/1993 | WO1993009142A1 Acute phase proteins for detection and prognosis of infection and tissue damage |
| 05/13/1993 | WO1993009141A1 Antigen associated with type i diabetes mellitus |
| 05/13/1993 | WO1993009137A1 Inhibitors of collagen-induced platelet aggregation |
| 05/13/1993 | WO1993009131A1 Method for isolating immunoglobulin compounds in the feces |
| 05/13/1993 | WO1993009130A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 05/13/1993 | WO1993008837A1 Stabilised antibodies |
| 05/13/1993 | WO1993008836A1 Induction of protection against viral infection by synergy between viral proteins and viral peptides |
| 05/13/1993 | WO1993008835A1 Cd8+ cell antiviral factor |
| 05/13/1993 | WO1993008829A1 Compositions that mediate killing of hiv-infected cells |
| 05/13/1993 | WO1993008817A1 Cd8 binding domain peptides |
| 05/13/1993 | WO1993005751A3 Osteogenic proteins in the treatment of bone deseases |
| 05/13/1993 | WO1992021697A3 Diagnostic peptides derived from m.tuberculosis antigens |
| 05/13/1993 | DE4200043A1 Recombinant CD30 antigen (KI-1) and corresp. nucleic acid - for diagnosis of anaplastic large-cell lymphoma, and for prepn. of antibodies and antisera, in immuno-absorption, etc. |
| 05/13/1993 | CA2124858A1 Suppressor and progenitor cells |
| 05/13/1993 | CA2122491A1 Tgf-.beta. type receptor cdnas and uses therefor |
| 05/13/1993 | CA2122359A1 Antigen associated with type i diabetes mellitus |
| 05/13/1993 | CA2122266A1 Cd8 binding domain peptides |
| 05/13/1993 | CA2122263A1 Induction of protection against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein |
| 05/13/1993 | CA2121683A1 A method for detecting a differentiation marker in normal and carcinoma cells and in biological samples and body fluid |
| 05/12/1993 | EP0541214A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 05/12/1993 | EP0540859A1 Anthracycline prodrugs |
| 05/12/1993 | EP0540687A1 Antibody-mediated cofactor-driven reactions |
| 05/12/1993 | EP0540675A1 Inhibition of mac-1 receptor binding to fibrinogen using d 30? homologs |
| 05/12/1993 | EP0540645A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 05/12/1993 | EP0540612A1 Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
| 05/12/1993 | EP0540591A1 Cell necrosis detection through assays for spectrin and breakdown products thereof. |
| 05/12/1993 | EP0540586A1 Binding domains |
| 05/12/1993 | EP0540525A1 Method of preparation of vaccines, and the use of the vaccines thus prepared |
| 05/12/1993 | EP0540512A1 Chimeric hiv-1-neutralizing immunoglobulins |
| 05/12/1993 | EP0160670B1 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 05/11/1993 | US5210181 T-lymphotropic retrovirus peptide |
| 05/11/1993 | US5210180 Nonapeptides |
| 05/11/1993 | US5210077 Antibodies to cytokinins having a glycosylated isoprenoid side chain and immunoassay methods |
| 05/11/1993 | US5210017 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/11/1993 | CA1317557C Breast tumor-associated antigen and monoclonal antibodies specific thereto |
| 05/11/1993 | CA1317544C Method for labeling antibodies with a metal ion |
| 05/09/1993 | WO1993009247A1 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
| 05/09/1993 | CA2100060A1 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
| 05/05/1993 | EP0540432A1 Determination of adulteration of durum wheat |
| 05/05/1993 | EP0540314A1 Monoclonal antibodies to polyacrylate polymers |
| 05/05/1993 | EP0540128A1 Nematode vaccine |
| 05/05/1993 | EP0540063A1 Hyperimmune serum for endotoxin associated disease, detoxified endotoxin and bacterial mutant |
| 05/05/1993 | EP0539975A1 Method for immunological assay of free lipoprotein-associated coagulation inhibitor (LACI) and kit therefor |
| 05/05/1993 | EP0539970A2 Methods for producing human lymphocytes and human monoclonal antibodies, and human monoclonal antibodies produced thereby |